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A 52-year-old female was admitted for further evalua-
tion of a continuous heart murmur. Transthoracic
echocardiography revealed a secundum type atrial sep-
tal defect (ASD II) with a size of 13 × 16 mm and con-
siderable left-to-right shunt (Qp/Qs = 2), as well as
elevated pulmonary artery pressure (RV/RA pressure
gradient = 38 mmHg). Primary invasive evaluation and
temporary closure of the ASD II using a sizing balloon
showed a further elevation of the left atrial pressure/left
ventricular end-diastolic pressure and consecutively of
the pulmonary artery pressure, reflecting a left ven-
tricular diastolic dysfunction. Therefore, theASD II was
left open and antihypertensive therapy with the an-
giotensin receptor blocker valsartan, at 80 mg per day,
was started. Three months later, the ASD II was suc-
cessfully occluded using an Amplatzer ASD occluder,
26 mm in diameter, without any further elevation of the
left ventricular filling pressures (fig. 1–4).
The atrial septum defect (ASD) is a common con-
genital lesion in adult patients. In 75% of cases, an
ASD is a hole-like defect in the ostium secundum (ASD
II) with a shunt flow from the “high pressure” left
atrium to the “low pressure” right atrium [1]. However,
an Eisenmenger reaction (right-to-left shunt) may, al-
though rarely, occur in untreated patients after years of
right heart overload with secondary pulmonary arte-
rial hypertension and subsequent hypertrophy of the
right atrium and ventricle. Patients usually develop
symptoms (e.g. dyspnoea during exercise, palpitations,
oedema, recurrent respiratory tract infections) in early
adulthood. Other typical complications are atrial fib-
rillation, heart failure and embolic events [1].
For decades, surgical closure of ASD has been con-
sidered the treatment of choice. Since the mid 1990s
transcatheter percutaneous device closure has estab-
lished itself as the favoured approach [2]. Nowadays,
85–90% of all ASDs in paediatric and adult patients
can be closed percutaneously [3]. The main advantages
of the percutaneous procedure are avoidance of open
heart surgery and hence avoidance of anaesthesia (in
case of intracardiac ultrasound as presented here, but
not with the use of transoesophageal echocardiography)
and of sternotomy with a thoracic
scar, shorter procedure time and
markedly shorter hospital stays [2].
In fact, the percutaneous procedure
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Figure 1
The device probe is introduced into the right atrium to visualise the
defect size, location and adequacy of the septal rims (arrows). The
device sheath is partially (dotted arrow) advanced into the left atrium.
RA = right atrium; LA = left atrium; IAS = interatrial septum.
Figure 2
The intracardiac echocardiography shows the appropriately deployed
Amplatzer septal occluder 26 mm (arrow) for atrial septal defect occlu-
sion in short axis view.
RA = right atrium; LA = left atrium.
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presented here with the help of intracardiac ultrasound
even lends itself to an outpatient setting.
For the percutaneous procedure, large occlusion
devices are used, because an ASD diameter of 30 to
40 mm is not uncommon. However, these devices may
irritate the aortic root and the risk of malpositioning
the device rises with increasing size. Both a patent
foramen ovale and an ASD may be accompanied by a
multiperforated septum or deficient interatrial rims,
making device placement and anchoring more chal-
lenging [1]. An appropriate additional imaging modal-
ity (beside X-ray) during the procedure is mandatory
to represent the exact anatomy of the defect and the
device placement during the procedure. Nowadays, ei-
ther transoesophageal or intracardiac echocardiogra-
phy has been established for this purpose. Intracardiac
echocardiography has several advantages such as im-
proved patient comfort, avoidance of anaesthesia and
hence easier logistics, as well as improved visualisa-
tion of the interatrial septum [4].
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Figure 4
Injection of contrast medium during angiography confirms the correct
position and configuration of the device (arrow) and excludes any
right-to-left-shunt.
RA = right atrium; LA = left atrium.
Figure 3
Intracardiac colour Doppler-echocardiography is used to rule out a
periprosthetic leak after device deployment in short axis view.
RA = right atrium; LA = left atrium.
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